Skip to main content
Equibles
ZBH logo

ZBH · Zimmer Biomet Holdings, Inc. · Metrics

Track ZBH — free

Use ZBH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ZBH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$88.83 -2.51 (-2.75%) At close · Sep 30
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$17.32B
Shares
190.74M
Volume · Sep 30 2.58M Avg daily vol (3M) 2.18M

ZBH metrics

88 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$88.83
Market cap
$17.32B

Price action

20 metrics
Price change (1W)
-2.8%
Price change (30D)
-8.7%
Price change (3M)
+6.1%
Price change (6M)
+1.0%
Price change (YTD)
+1.6%
Price change (1Y)
-7.1%
Trailing year
Price change (5Y)
—
52-week high
$103.98
52-week low
$79.58
Change from 52-week high
-12.2%
Change from 52-week low
+14.8%
Annualized volatility
32.3%
Annualized volatility (3M)
32.7%
Beta
0.2
RSI (14D)
40.5
Price vs SMA 50
-5.0%
Price vs SMA 200
-0.1%
Avg volume (3M)
2.21M
Relative volume
0.7
Average dollar volume
$208.30M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
190.74M

Valuation

12 metrics
P / E (TTM)
22.2
Trailing earnings · reciprocal yield 4.5%
PEG ratio
0.7
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2.0×
reciprocal yield 49.1%
P / book
1.4
reciprocal yield 72.9%
FCF yield
8.8%
TTM · current market cap
Buyback yield
4.3%
P / FCF
11.4
reciprocal yield 8.8%
P / operating cash flow
9.9
reciprocal yield 10.1%
Earnings yield
4.7%

Historical valuation

8 metrics
P / E historical average (3Y)
25.4×
reciprocal yield 3.9%
P / E historical average (5Y)
37.7×
reciprocal yield 2.7%
EV / revenue historical average (3Y)
3.4×
reciprocal yield 29.1%
EV / revenue historical average (5Y)
3.8×
reciprocal yield 26.6%
EV / EBIT historical average (3Y)
22.3×
reciprocal yield 4.5%
EV / EBIT historical average (5Y)
29.5×
reciprocal yield 3.4%
EV / EBITDA historical average (3Y)
11.8×
reciprocal yield 8.5%
EV / EBITDA historical average (5Y)
14.0×
reciprocal yield 7.2%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
23.4%
Shareholder yield
5.4%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
—
Operating margin
14.2%
Trailing 12 months
Net margin
9.5%
Gross profit (TTM)
$4.30B
Operating profit (TTM)
$1.21B
Net income (TTM)
$806.70M
Trailing 12 months
Diluted EPS (TTM)
$4.12
FCF margin
17.9%
Effective tax rate
13.5%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$26.30

Growth

11 metrics
Revenue growth YoY
+4.8%
Year over year
Net income growth YoY
+29.8%
Revenue (TTM)
$8.51B
Trailing 12 months
EPS growth YoY
+33.8%
Shares change YoY
-2.8%
Year over year · fewer shares
Revenue CAGR (3Y)
+5.9%
Revenue CAGR (5Y)
+6.1%
EPS CAGR (3Y)
+47.8%
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+8.0%
FCF CAGR (5Y)
+6.2%

Quality

14 metrics
Return on equity
6.4%
Return on assets
3.5%
Debt / equity
0.6
Current ratio
1.7
EBITDA (TTM)
$2.31B
Free cash flow (TTM)
$1.52B
Quick ratio
0.9
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$410.00M
Total assets
$22.80B
Total debt
$7.48B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.74B
Capital expenditures (TTM)
$220.30M
R&D (TTM)
$442.80M
SG&A (TTM)
$3.43B
Stock compensation (TTM)
$98.20M
R&D / revenue
5.2%
Stock compensation / revenue
1.2%

Ownership (13F)

3 metrics
13F filers
916
13F filer change QoQ
-7
Institutional ownership
104.6%

Short interest

3 metrics
Short interest
4.5%
Latest settlement · 4.4 days to cover
Days to cover
4.4d
Short-squeeze score
62 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$824,028
Insider-sentiment score
37 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1136869 CUSIP 98956P102 13F (30d) 29 filings 17 filers Visit website Investor relations